hB1F and HNF1 work synergistically in the regulation of the function of HBV EN II

Science China Press., Co. Ltd. - Tập 46 - Trang 133-136 - 2001
Yanning Cai1, Mei Li1, Qing Zhou1, Yuying Kong1, Yuan Wang1
1Shanghai Institute of Biochemistry, Chinese Academy of Sciences, Shanghai, China

Tóm tắt

Human B1 binding factor (hB1F) is a novel transcription factor cloned in our laboratory, which has the capacity of binding the Bl region of HBV enhancer II (EN II) and stimulating its activity. In this report, the functional relationship between hB1F and other liver-enriched activators of EN II was investigated. The results of CAT assay indicated that there was only additive effect between hB1F and HNF4 as well as HNF3β. On the contrary, the presence of both hB1F and HNF1 would result in significant functional synergism. Further GST pull down assay indicated that hB1F could interact with HNF1 directlyin vitro. This study provides the evidence that hB1F and HNF1 work synergistically in the regulation of the activity of HBV EN II.

Tài liệu tham khảo

Wang, Y., Chen, P., Wu, X. et al., A new enhancer element, EN II, identified in the X gene of hepatitis B viras, J. Virol., 1990, 64: 3977. Wang, W. X., Li, M., Wu, X. et al., HNF1 is critical for the liverspecific function of HBV enhancer II, Res. Virol., 1998, 149: 99. Li, M., Xie, Y. H., Wu, X. et al., HNF3 binds and activates the second enhancer, EN II, of hepatitis B viras, Virology, 1995, 214: 371. Raney, A. K., Johnson, J. L., Palmer, C. N. et al., Members of the nuclear receptor superfamily regulate transcription from the hepatitis B viras nucleocapsid promoter, J. Virol., 1997, 71: 1058. Lopez-Cabrera, M., Letovsky, J., Hu, K. Q. et al., Multiple liverspecific factors bind to the hepatitis B viras core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein, Proc. Natl. Acad. Sci. USA, 1990, 87: 5069. Li, M., Xie, Y. H., Kong, Y. Y. et al., Cloning and characterization of a novel human hepatocyte transcription factor, hBlF, which binds and activates EnhancerII of hepatitis B viras, J. Biol. Chem., 1998, 273: 29022. Wu, X., Zhu, L., Li, Z. P. et al., Functional organization of Enhancer (EN II) of hepatitis B viras, Virology, 1992, 191: 490. Ktistaki, E., Talianidis, I., Modulation of hepatic gene expression by hepatocyte nuclear factor 1, Science, 1997, 277: 109. Sambrook, J., Fritsch, E. F., Maniatis, T., Molecular Cloning: A Laboratory Mannual, 2nd ed., New York: Cold Spring Harbour Press, 1989, 808. Gorman, C. M., Moffat, L. F., Howard, B. H., Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells, Mol. Cell Biol., 1982, 2: 1044. Sock, E., Enderich, J., Wegner, M., The J domain of papovaviral large tumor antigen is required for synergistic interaction with the POU-domain protein Tst-l/Oct6/SCIP, Mol. Cell Biol., 1999, 19: 2455. Shen, C. H., Stavnezer, J., Interaction of stat6 and NF-kappaB: direct association and synergistic activation ofinterleukin-4-induced transcription, Mol. Cell Biol., 1998, 18: 3395. Lai, J. S., Herr, W., Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations, Proc. Natl. Acad. Sci. USA, 1992, 89: 6958. Tremblay, J. J., Marcil, A., Gauthier, Y. et al., Ptxl regulates SF-1 activity by an interaction that mimics the role of the ligand-binding domain, EMBO J., 1999, 18: 3431. Galarneau, L., Pare, J. F., Allard, D. et al., The alphal-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family, Mol. Cell Biol., 1996, 16: 3853.